Climb Bio to Present at Upcoming Investor Conferences
Climb Bio (Nasdaq: CLYM) has announced its executive team's participation in four major upcoming healthcare investor conferences. The schedule includes appearances at the Guggenheim Securities Healthcare Innovation Conference (Nov 11-12), Stifel Healthcare Conference (Nov 18-19), Piper Sandler Healthcare Conference (Dec 3-5), and Evercore ISI HealthCONx Conference (Dec 3-5). Each event will feature fireside chats and one-on-one investor meetings. All presentations will be webcast live and available for replay on the company's website under the Investors section.
Climb Bio (Nasdaq: CLYM) ha annunciato la partecipazione del suo team esecutivo a quattro importanti conferenze per investitori nel settore sanitario. Il programma include presenze alla Guggenheim Securities Healthcare Innovation Conference (11-12 novembre), alla Stifel Healthcare Conference (18-19 novembre), alla Piper Sandler Healthcare Conference (3-5 dicembre) e alla Evercore ISI HealthCONx Conference (3-5 dicembre). Ogni evento presenterà conversazioni informali e incontri individuali con gli investitori. Tutte le presentazioni saranno trasmesse in diretta streaming e disponibili per la visione in replay nella sezione Investitori del sito web dell'azienda.
Climb Bio (Nasdaq: CLYM) ha anunciado la participación de su equipo ejecutivo en cuatro importantes conferencias para inversores del sector sanitario. El calendario incluye apariciones en la Guggenheim Securities Healthcare Innovation Conference (11-12 de noviembre), la Stifel Healthcare Conference (18-19 de noviembre), la Piper Sandler Healthcare Conference (3-5 de diciembre) y la Evercore ISI HealthCONx Conference (3-5 de diciembre). Cada evento contará con charlas informales y reuniones uno a uno con los inversores. Todas las presentaciones se transmitirán en vivo y estarán disponibles para su reproducción en el sitio web de la empresa en la sección de Inversores.
Climb Bio (Nasdaq: CLYM)는 임원팀이 다가오는 네 개의 주요 의료 투자자 회의에 참석할 것이라고 발표했습니다. 일정에는 구겐하임 증권 의료 혁신 회의 (11-12일 11월), 스티펠 의료 회의 (18-19일 11월), 파이퍼 샌들러 의료 회의 (3-5일 12월) 및 에버코어 ISI HealthCONx 회의 (3-5일 12월) 참여가 포함됩니다. 각 이벤트에서는 대화식 채팅 및 1대1 투자자 회의가 진행됩니다. 모든 발표는 실시간으로 방송되며 회사 웹사이트의 투자자 섹션에서 다시 볼 수 있습니다.
Climb Bio (Nasdaq: CLYM) a annoncé la participation de son équipe dirigeante à quatre grandes conférences d'investisseurs dans le secteur de la santé. Le programme comprend des apparitions à la Guggenheim Securities Healthcare Innovation Conference (11-12 novembre), à la Stifel Healthcare Conference (18-19 novembre), à la Piper Sandler Healthcare Conference (3-5 décembre) et à la Evercore ISI HealthCONx Conference (3-5 décembre). Chaque événement présentera des discussions informelles et des réunions individuelles avec des investisseurs. Toutes les présentations seront diffusées en direct et disponibles en replay dans la section Investisseurs du site web de la société.
Climb Bio (Nasdaq: CLYM) hat die Teilnahme seines Führungsteams an vier wichtigen bevorstehenden Investorenkonferenzen im Gesundheitswesen bekannt gegeben. Der Zeitplan umfasst Auftritte auf der Guggenheim Securities Healthcare Innovation Conference (11.-12. November), der Stifel Healthcare Conference (18.-19. November), der Piper Sandler Healthcare Conference (3.-5. Dezember) und der Evercore ISI HealthCONx Conference (3.-5. Dezember). Jede Veranstaltung wird informelle Gespräche und persönliche Meetings mit Investoren anbieten. Alle Präsentationen werden live übertragen und auf der Unternehmenswebsite im Bereich Investoren zum Nachspielen verfügbar sein.
- None.
- None.
WELLESLEY, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced that members of its executive team are scheduled to participate in the upcoming investor conferences detailed below.
Guggenheim Securities Healthcare Innovation Conference
Format: Fireside chat and one-on-one investor meetings
Date: November 11-12, 2024
Stifel 2024 Healthcare Conference
Format: Fireside chat and one-on-one investor meetings
Date: November 18-19, 2024
36th Annual Piper Sandler Healthcare Conference
Format: Fireside chat and one-on-one investor meetings
Date: December 3-5, 2024
7th Annual Evercore ISI HealthCONx Conference
Format: Fireside chat and one-on-one investor meetings
Date: December 3-5, 2024
The presentations will be webcast live and available for replay under “News & Events” in the Investors section of the Company's website at climbbio.com.
About Climb Bio, Inc.
Climb Bio, Inc., is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to treat a broad range of B-cell mediated diseases. For more information, please visit climbbio.com.
Investors
Chris Brinzey
ICR Healthcare
chris.brinzey@ICRhealthcare.com
339-970-2843
Media
Jon Yu
ICR Healthcare
jon.yu@icrhealthcare.com
475-395-5375
FAQ
What investor conferences will Climb Bio (CLYM) attend in late 2024?
Where can investors watch Climb Bio's (CLYM) conference presentations?
What type of sessions will Climb Bio (CLYM) participate in at these conferences?
